General Toxicity Test for Pharmaceutical Safety Evaluation
Support for toxicity testing from the screening stage to entering clinical trials!
Inari Research supports toxicity testing from the screening stage until entering clinical trials (clinical studies). We conduct a wide range of tests based on our extensive testing experience and accumulated background data in standard test systems such as mice, rats, rabbits, dogs, and of course, monkeys. The tests are conducted in a GLP-compliant facility that has obtained certification from AAALAC International (Association for Assessment and Accreditation of Laboratory Animal Care International). We can complete a series of non-clinical test sets, including genotoxicity tests and safety pharmacology tests necessary to enter clinical trials (Phase I), with the final report preparation finished within six months. 【Main Types of Tests】 ■ Single-dose tests ■ Expanded single-dose toxicity tests ■ Repeated dose tests for 2 weeks, 4 weeks (1 month), 13 weeks (3 months), 26 weeks (6 months), 39 weeks (9 months), and 52 weeks (12 months) ■ Various dose-setting tests ■ General toxicity tests in the drug discovery exploration stage, etc. *For more details, please refer to the PDF document or feel free to contact us.
- Company：イナリサーチ
- Price：Other
